U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07333482) titled 'Flourish: Studying the Early Infant Gut Microbiome' on Dec. 16, 2025.
Brief Summary: The goal of this clinical trial is to learn whether microbiome analysis, education, and personalized recommendations can improve gut health and reduce early markers of immune-related conditions in infants aged 0-3 months delivered via Cesarean section. The study aims to determine whether these interventions can increase beneficial bacteria, decrease C-section-associated microbiome signatures, reduce opportunistic pathogens, and improve functional potential for HMO digestion and SCFA production. The study also seeks to assess whether improvements in ...